[{"id":"fbc4a57d-196c-41c2-ba51-81874dc4d553","acronym":"","url":"https://clinicaltrials.gov/study/NCT02030184","created_at":"2021-03-16T19:52:12.023Z","updated_at":"2024-07-02T16:36:54.486Z","phase":"Phase 1/2","brief_title":"Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas","source_id_and_acronym":"NCT02030184","lead_sponsor":"University of Maryland, Baltimore","biomarkers":" SSTR2","pipe":" | ","alterations":" SSTR2 expression","tags":["SSTR2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SSTR2 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e topotecan • Tozaride (Rhenium (Re) 188 P2045)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 06/01/2017","start_date":" 06/01/2017","primary_txt":" Primary completion: 06/01/2019","primary_completion_date":" 06/01/2019","study_txt":" Completion: 06/01/2021","study_completion_date":" 06/01/2021","last_update_posted":"2019-10-17"}]